[The use of a sedative neuroleptic agent, sultopride, in posttraumatic Korsakoff syndrome in a young adult].
In a young woman with a post-traumatic Korsakoff syndrome exhibiting agitation and anxiety, sedative drugs were difficult to use as they either exacerbated confusion or generated ataxia. Administration of meprobamate with oral sultopride in a high dosage (2 g per day) was promptly followed by an improvement in the patient's condition. Doses were therefore rapidly tapered (over approximately a month and a half). Complete recovery, which is the well-known outcome, thus took place in favorable conditions, as anxiety and agitation no longer hindered the patient's relationships with others.
D000328:Adult; D000077582:Amisulpride; D006259:Craniocerebral Trauma / Q000150:complications; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008620:Meprobamate / Q000008:administration & dosage; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D011619:Psychotropic Drugs / Q000008:administration & dosage*; D013469:Sulpiride / Q000008:administration & dosage / Q000031:analogs & derivatives*
D011619:Psychotropic Drugs; D013469:Sulpiride; D000077582:Amisulpride; D008620:Meprobamate
Utilisation d'un neuroleptique sédatif, le sultopride, dans le cadre d'un syndrome de korsakoff post-traumatique chez un adulte jeune.